Publicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (2)

2024

  1. Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study

    Breast, Vol. 77

2022

  1. Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

    Frontiers in Oncology, Vol. 11